RSPI (RespireRx Pharmaceuticals) OCF Yield %: -29.21 (As of Jul. 11, 2026)

What is RespireRx Pharmaceuticals OCF Yield %?

RespireRx Pharmaceuticals RSPI 12 OCF Yield % is -29.21 as of Jul. 11, 2026. GuruFocus rates RSPI with a GF Score™ of 12/100.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, RespireRx Pharmaceuticals's Trailing 12-Month Cash Flow from Operations is $-0.25 Mil, and Market Cap is $0.85 Mil. Therefore, RespireRx Pharmaceuticals's OCF Yield % for today is -29.21%.

The historical rank and industry rank for RespireRx Pharmaceuticals's OCF Yield % or its related term are showing as below:

RSPI' s OCF Yield % Range Over the Past 10 Years
Min: -47.78 Med: 0 Max: -29.18
Current: -29.21

During the past 13 years, the highest OCF Yield % of RespireRx Pharmaceuticals was -29.18%. The lowest was -47.78%. And the median was %.

RSPI's OCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -8.05 vs RSPI: -29.21

RespireRx Pharmaceuticals's OCF Margin % for the quarter that ended in Sep. 2023 was %.

RespireRx Pharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

RespireRx Pharmaceuticals OCF Yield % Related Terms

RespireRx Pharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for RespireRx Pharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RespireRx Pharmaceuticals OCF Yield % Chart

RespireRx Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

OCF Yield %

Get a 7-Day Free Trial

-16.97

-116.76

-24.82

-83.47

-49.87

RespireRx Pharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
OCF Yield %	Get a 7-Day Free Trial															-27.87	15.24	-20.61	-155.85	-123.11

RSPI vs CNBX, NAVB, IPIX: OCF Yield % Comparison

For the Biotechnology subindustry, RespireRx Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RespireRx Pharmaceuticals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RespireRx Pharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where RespireRx Pharmaceuticals's OCF Yield % falls into.

Save Embed

12GF Score

RespireRx Pharmaceuticals Inc RSPI

OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

RespireRx Pharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

RespireRx Pharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

OCF Yield %	=	Cash Flow from Operations	/	Market Cap
	=	-0.144	/	0.2887512
	=	-49.87%

RespireRx Pharmaceuticals's annualized OCF Yield % for the quarter that ended in Sep. 2023 is calculated as

OCF Yield %	=	Cash Flow from Operations	*	Annualized Factor	/	Market Cap
	=	-0.101	*	4	/	0.3281619
	=	-123.11%

Frequently Asked Questions Learn more about OCF Yield % →

What does a OCF Yield % of -29.21 mean?

RespireRx Pharmaceuticals (RSPI) has a OCF Yield % of -29.21 as of Jul. 11, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on RespireRx Pharmaceuticals and its competitors.

Is RespireRx Pharmaceuticals' OCF Yield % too high?

RespireRx Pharmaceuticals' current OCF Yield % is -29.21. Overall, RespireRx Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does RespireRx Pharmaceuticals' OCF Yield % compare to CNBX and NAVB?

RespireRx Pharmaceuticals' OCF Yield % of -29.21 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Yield % for a Biotechnology company?

A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Yield % mean?

A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on RespireRx Pharmaceuticals and its competitors. RespireRx Pharmaceuticals's current OCF Yield % is -29.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is RespireRx Pharmaceuticals stock overvalued right now?

RespireRx Pharmaceuticals (RSPI) has a current OCF Yield % of -29.21. The current OCF Yield % is -29.21. RespireRx Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Yield % calculated?

OCF Yield % is calculated from a company's financial statements. For RespireRx Pharmaceuticals (RSPI), the current OCF Yield % is -29.21 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RespireRx Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies CNBX NAVB IPIX PPCB ATRX PKBO EFTR ARDS NYMXF IVRN OCSE:NOVO B REGN VRTX ASX:CSL XKRX:207940 ALNY XBRU:UCB XKRX:068270 MRNA XBRU:ARGX

Address 126 Valley Road, Suite C, Glen Rock, NJ, USA, 07452

Website http://www.respirerx.com

RespireRx Pharmaceuticals Inc is engaged in the discovery, value-added development, and commercialization through partners of pharmaceuticals for the treatment of neurological and psychiatric disorders. The pipeline products of the company are dronabinol which is in a 505(b)(2) development ideas for the treatment of OSA (Obstructive Sleep Apnea), a form of sleep apnea; AMPAkines CX1739 for the treatment of bladder control and other conditions associated with spinal injury; CX717 for ADHD and CX1942 which is an injectable dosage formulation and GABAkines lead KRM-II-81 in preclinical development for treatment resistant epilepsy and non-opioid pain management.

12GF Score

Get the complete analysis for RSPI

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View RSPI Analysis

See OCF Yield % data for all stocks →